DiMe’s sDHT Adoption Navigator helps clinical teams move from guidance to action, but the real test is whether organizations use it early enough to matter.
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- What Clinical Analytics Solutions Are Shaping Clinical Research
- Sites Are Building Their Own Tech – SCRS On What That Means
- Human-In-The-Loop In AI Validation And Control: From Principle To Practice
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
- HTA, Digital Twins, And Building Clinical Tech That Lasts
- Real-World Evidence And Wearables Are Reshaping Trial Tech
- Navigating Elsa's AI Transition: Practical Guidance To Safeguard Confidential Information (Part 3)
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Unified Patient Apps: The Future Of Trial Simplicity
A unified patient app streamlines clinical trial participation by combining scheduling, questionnaires, travel, and payments—reducing burden, improving engagement, and supporting better retention and data quality.
-
AI-Powered Breakthroughs In CNS And Pain Trials
Discover how AI-powered tools like EEG are revolutionizing neurological and pain clinical trials by replacing subjectivity with precision and drastically accelerating the path to approval.
-
eTMFs Uncovered: 5 Costly Misconceptions To Avoid
Critically examine prevalent myths surrounding electronic Trial Master Files (eTMFs) and their integration with electronic Investigator Site Files (eISFs).
-
The Ten Commandments Of Vendor Selection
Selecting the right vendors sets the foundation for efficient operations and reliable outcomes, and these ten essential principles can guide sponsors in making informed vendor choices.
-
Dysfunctions Of Clinical Trial Vendor Selection And Overcoming Them
Vendor selection often fails due to five common dysfunctions. Identifying and addressing them early improves alignment, trust, and trial performance—avoiding costly delays.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
Proven Process For Managing Clinical Trial Changes, Data Migrations
Explore how the Imperial College London was able to complete a successful migration of 14 ongoing studies, involving over 1,700 patients and 150,000+ forms, within a 16-month timeframe.
-
Patient Voice Impacts Treatment Experience
Download this guide for five key recommendations on how to build an eCOA strategy in your next oncology trial that keeps your patient's voice front and center in their care.
-
Build Versus Buy: What's The Best Tech Tool For Study Activation?
In the case of study activation, there are several compelling reasons that buying an appropriate purpose-built system is a better choice than taking on the challenge of building a study activation tool.
-
How eConsent Can Help Legally Authorized Representatives
Software vendors often forget to think about the needs of LARs, even though they play a vital role in clinical trials. Explore three ways eConsent can help LARs complete the informed consent process.
- DiMe's Navigator: Why Teams Still Stall On Digital Endpoints
- Digital Endpoints Are Ready. Clinical Development Isn't
- Why Clinical Trial Data Cleaning Must Go Continuous (And How To Do It)
- Sites Are Building Their Own Tech – SCRS On What That Means
- When The System Breaks, Who Pays? SCRS On Site Tech Gaps
RECENT NEWSLETTERS
- 05.07.26 -- How AI, ICH E6(R3) & RWD Are Reshaping Clinical Trials
- 05.02.26 -- Best Of April: AI In Clinical Trials — What Working
- 04.30.26 -- AI, RWE & Predictive Analytics Are Reshaping Trials
- 04.23.26 -- Smarter Trials Start Here: Data Quality, AI & Infrastructure Insights
- 04.16.26 -- 5 eTMF Questions, Agentic AI's Real Impact On Clinical Trials & More